The Daily Populous

Saturday February 22nd, 2020 day edition

image for A woman in Canada tested positive after traveling to Iran. That has got health officials concerned

Canada’s chief public health officer Theresa Tam has raised concerns over a woman who tested positive for coronavirus after recently returning from Iran.

"Any important cases linked to Iran could be an indicator that there is more widespread transmission than we know about," Tam said.

On Friday, the Middle Eastern country confirmed a total of 18 patients with coronavirus and four deaths.

The Canadian woman, in her 30, is the sixth case of novel coronavirus in British Columbia and the ninth for Canada overall.

“So this leads to the need for further investigation for the officials on the ground," in British Columbia, she said.

Iran outbreak: The novel coronavirus has spread to several Iranian cities, including the capital Tehran, according to the Iranian health ministry.

“The spread of the coronavirus started in Qom and has reached other cities in the country like Tehran, Babol, Arak, Isfahan, Rasht and other cities due to people traveling. »

Russia Doesn't Want Bernie Sanders. It Wants Chaos

Authored by wired.com

Which is why it should be no great surprise that, as The Washington Post first reported Friday, US officials warned Bernie Sanders that Russia is “attempting to help” his presidential campaign.

“I don’t care, frankly, who [Russian President Vladimir] Putin wants to be president,” Sanders said in a statement to the Post.

But it does speak to what experts say is Russia’s ultimate goal, which is less about Sanders and more about promoting chaos. »

'Magic mushroom' drug reduces anxiety and depression in cancer patients for five years

Authored by edition.cnn.com

(CNN) A single dose of psilocybin, a compound found in "magic mushrooms," provides long-term relief of anxiety and depression in cancer patients, a new study finds.

In fact, cancer patients who were given psilocybin reported reductions in anxiety, depression, hopelessness, demoralization, and death anxiety more than four years after receiving the dose in combination with psychotherapy.

By 6½ months, after all patients had received psilocybin, about 60% to 80% showed clinically significant reductions in depression, anxiety and existential distress and and improved attitudes toward death. »